IGI Laboratories (NYSE:IG) will be releasing its earnings data on Tuesday, April 29th. Investors interested in registering for the company’s conference call can do so using this link.
IGI Laboratories (NYSE:IG) last posted its quarterly earnings results on Thursday, February 27th. The company reported ($0.01) EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.01 by $0.02. On average, analysts expect IGI Laboratories to post $0.03 EPS for the current fiscal year and $0.15 EPS for the next fiscal year.
Shares of IGI Laboratories (NYSE:IG) opened at 4.91 on Monday. IGI Laboratories has a 1-year low of $1.24 and a 1-year high of $6.14. The stock has a 50-day moving average of $5.03 and a 200-day moving average of $3.53. The company’s market cap is $230.9 million. IGI Laboratories also was the recipient of a large growth in short interest in April. As of April 15th, there was short interest totalling 279,070 shares, a growth of 79.4% from the March 31st total of 155,561 shares. Currently, 2.2% of the shares of the stock are sold short. Based on an average daily trading volume, of 272,377 shares, the short-interest ratio is currently 1.0 days.
On a related note, analysts at Craig Hallum initiated coverage on shares of IGI Laboratories in a research note on Monday, April 21st. They set a “buy” rating and a $7.50 price target on the stock.
IGI Laboratories, Inc (NYSE:IG) develops, manufactures, fills and packs topical semi-solid and liquid products for cosmetic, cosmeceutical and pharmaceutical customers.
Receive News & Ratings for IGI Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IGI Laboratories and related companies with Analyst Ratings Network's FREE daily email newsletter.